Attached files
| file | filename |
|---|---|
| 8-K - 8-K - SUPERNUS PHARMACEUTICALS, INC. | a15-21143_18k.htm |
Exhibit 16.1
October 15, 2015
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K dated October 15, 2015 of Supernus Pharmaceuticals, Inc. and are in agreement with the statements contained in the third paragraph of 4.01 (a) on page 2 therein. We have no basis to agree or disagree with other statements of the registrant contained therein.
|
/s/Ernst & Young LLP |
|
|
Ernst & Young LLP |
|